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Lossof heterozygosity (LOH)of theadenomatouspol-
yposis coli (APC) gene triggers a series of molecular
events leading to intestinal adenomagenesis. Hap-
loinsufficiency of the cohesin Rad21 influences multi-
ple initiating events in colorectal cancer (CRC). We
identifyRad21asagatekeeperofLOHandab-catenin
target gene and provide evidence that Wnt pathway
activation drives RAD21 expression in human CRC.
Genome-wide analyses identified Rad21 as a key
transcriptional regulator of critical CRC genes and
long interspersed element (LINE-1 or L1) retrotrans-
posons. ElevatedRAD21 expression trackswith reac-
tivation of L1 expression in human sporadic CRC,
implicating cohesin-mediated L1 expression in global
genomic instability and gene dysregulation in cancer.INTRODUCTION
Molecular pathways leading to colorectal carcinoma (CRC) are
among the best defined of all cancers. Adenomatous polyposis
coli (APC) gene mutations occur in most CRCs. Patients with fa-
milial polyposis (FAP) carry a heterozygous mutation in the APC
gene (Cottrell et al., 1992), and loss of the second normal APC
allele (loss of heterozygosity [LOH]) is necessary for colon polyp
formation (Spirio et al., 1998). APCWT LOH is also a critical and
early event in sporadic CRC (Clevers and Nusse, 2012; Cottrell
et al., 1992). Mutant APC alleles mostly encode truncated pro-
teins with compromised ability to regulate b-catenin degrada-Cell Retion, allowing its nuclear translocation activating the canonical
signaling pathway (Clevers and Nusse, 2012). APC truncation
also compromises cytokinesis and chromosome segregation
(Caldwell et al., 2007; Dikovskaya et al., 2007).
A central feature in most CRCs is chromosomal instability
(CIN). Common mutations in CIN genes were recently identified
in CRC (Barber et al., 2008). Strikingly, four of the five genes
encode proteins essential for sister chromatid cohesion (SCC)
(Nasmyth, 2001), suggesting that defects in SCC may underpin
CIN. Indeed, small interfering RNA (siRNA) knockdown of SCC
genes do show increased CIN (Barber et al., 2008).
SCC maintains physical connection between sister chroma-
tids, ensuring balanced bipolar separation of chromatids in cell
division (Nasmyth, 2001). SCC is also essential for homologous
recombination (HR)-dependent repair of DNA breaks (Jess-
berger, 2009) and regulation of gene expression (Dorsett,
2011). SCC is orchestrated by the cohesin complex consisting
of four subunits: Smc1, Smc3, Rad21/Scc1, and Scc3 (Nasmyth,
2001). Three of these subunits form a triangular or ring-shaped
structural backbone, while the fourth subunit, Scc3, binds the
complex through Rad21, which serves as the bridging protein
linking the other three subunits (Haering et al., 2008).
We have been investigating Rad21/RAD21 in mouse gastroin-
testinal (GI) and human cancers (McKay et al., 1996; Xu et al.,
2010, 2011b; Yan et al., 2012). Unlike other cohesins, RAD21
dysregulation rather than mutations is common in epithelial
cancers, including CRC (Barber et al., 2008; Deb et al., 2014;
Xu et al., 2011a). Elevated RAD21 expression is associated
with poor cancer prognosis (Deb et al., 2014; Xu et al., 2010,
2011b; Yan et al., 2012), while Rad21 haploinsufficiency leads
to defective response to radiation-induced damage, increased
CIN, and HR deficiency (Xu et al., 2010).ports 9, 1781–1797, December 11, 2014 ª2014 The Authors 1781
Despite the emerging importance of cohesin in cancer biology,
how cohesin dysfunction contributes to carcinogenesis remains
elusive (Xu et al., 2011a). Here, we report a comprehensive study
of Rad21’s role in GI carcinogenesis in mouse models and pri-
mary human cancers. Using the ApcMin mouse, a well-charac-
terized model of FAP (Moser et al., 1992), we elucidate multiple
roles of Rad21 in mediating early molecular events leading to ad-
enoma formation.
RESULTS
Ex Vivo ApcWT LOH in Organoids Is DNA Damage
Inducible
As ApcWT allelic LOH is thought to be the key early event in ad-
enomagenesis, we asked if this event could be detected prior to
the formation of any microscopically identifiable lesions and,
furthermore, if this could be modulated in vitro. We developed
an assay to detect ApcWT LOH using ex vivo cultured organoids
frommouse small intestinal (SI) crypts (Figure 1A).ApcMin/+ orga-
noids were morphologically indistinguishable from those of wild-
type (WT). Occasional cyst-like colonies (‘‘de novo adenomas’’)
were observed. These became more frequent when primary
organoids were replated (Figure 1A). Cyst-like organoids phe-
nocopied cultures established directly from adenomas.
LOHwas determined in individual organoids using a restriction
fragment length polymorphism (RFLP) assay. Individual orga-
noids generate multiple crypt-like projections (Figure 1A), thus
containing a population of mixed clones. Accordingly, we
set parameters for measuring LOH: a Min/WT allelic ratio
of <1.2 as no LOH, while LOH includes those in transition
(Min/WT > 1.2) and those with completed LOH (no detectable
or negligible WT allele; Figure S1A). Analysis revealed that
a significant proportion (88%) of organoids were in transition,
whereas only 0.6% organoids had completed LOH (Figure 1B).
Remarkably, 85% of cyst-like organoids had completed LOH
(Figures 1B and S1B). Coincident with the complete loss of the
WT allele, full-length Apc protein was undetectable in cyst-like
organoids (Figure S1C). Immunohistochemistry (IHC) further
confirmed aberrant b-catenin subcellular localization, as a result
of ApcWT LOH, in primary organoids and in cyst-like organoids
(Figure S1D). No statistical difference in LOH in organoids estab-
lished from different regions of SI existed (Figure S1E).
Since ApcWT LOH had been shown to be HR dependent (Hai-
gis and Dove, 2003), we predicted that ApcWT LOH is induced by
DNA damage. We treated ApcMin/+ organoids with hydrogen
peroxide (H2O2). H2O2, a byproduct of endogenous oxidative
metabolism, generates free radicals and oxygen species that
induce DNA damage, including DNA double-strand breaks
(DSBs) that are preferentially repaired by HR-dependent DNA
repair. DSBs marked by the presence of gH2AX foci were clearly
evident in organoids following H2O2 treatment (Figure 1C).
ApcWT LOH was detected in 100% organoids, a significant in-
crease above untreated (Figure 1B; Table S1).
Extensive CIN Is Evident following ApcWT LOH
We next investigated the status of CIN in the context of ApcWT
LOH. Epithelial cells of SI primary organoids mostly maintained
normal ploidy (>85% diploid), with no statistical differences be-1782 Cell Reports 9, 1781–1797, December 11, 2014 ª2014 The Auttween WT and ApcMin/+ cells (Figure 1D; Table S2). However in
cyst-like secondary organoids and in cell cultures established
from ApcMin/+ adenomas, aneuploidy (predominantly hypo-
ploidy) was observed in 65%–67% of cells (Figure 1D; Table
S2). ApcMin/+ mouse embryonic fibroblasts (MEFs) exhibited a
significantly higher frequency of aneuploidy (Figure 1D; Table
S2) and abnormal mitotic cells, with multipolar spindles being
the most frequent form (Figures 1E and 1F).
Rad21 Haploinsufficiency Delays Adenomagenesis
in ApcMin/+ Mice
Given that cohesin is required for both HR and accurate chromo-
some segregation, the two processes implicated in the initiation
of adenomagenesis, we set out to address any such role of
cohesin by evaluating mutant mice lacking one Rad21 allele.
Rad21 expression was detected predominantly in nuclei of mul-
tiple cell types in GI, including epithelial cells of both crypts and
villi along the entire SI as well as the colonic crypts (Figure S2A).
The most intense signal was observed in Paneth cells, which
support the leucine-rich repeat-containing G protein-coupled re-
ceptor 5 (Lgr5)-positive intestinal stem cells (ISCs; Figure S2B).
Rad21 expression showed no regional differences in SI (Fig-
ure S2C) but was significantly reduced in both small and large
intestinal crypts of Rad21+/ mice (Figure S2D).
When compared with ApcMin/+ mice, double-mutant ApcMin/+:
Rad21+/ mice showed statistically increased survival (Fig-
ure 2B). The presence of multiple adenomas, predominantly in
the SI and, to lesser extent, in the colon or both, was confirmed
in a subset of sick mice (Figure 2B). ApcMin/+:Rad21+/ exhibited
a significant reduction in tumor incidence (20/24 [83.3%]
compared to 43/43 [100%] for ApcMin/+ mice; Table S3). Ade-
noma numbers were not significantly different at different GI
sites between genotypes (Figure S2E). Further, two out of six
(33.4%) ApcMin/+:Rad21+/ animals developed adenomas at a
young age (<100 days), a significant decrease compared to
seven out of seven (100%) ApcMin/+mice (Table S3). The number
and size of SI adenomas was also significantly reduced in young
ApcMin/+:Rad21+/ mice (Figures 2C and S2F). These results
indicate a delay in SI adenoma formation on a Rad21+/ genetic
background.
Rad21 Haploinsufficiency Impedes ApcWT LOH and
Resolves Aneuploidy in ApcMin/+ Cells
Organoids from ApcMin/+:Rad21+/ mice showed a significant
reduction in the frequency of ApcWT LOH (Figure 2D). Adenomas
harvested frommice showedLOH in 37 out of 39 (94.5%)ApcMin/+
and 10 out of 11 (90%) in ApcMin/+:Rad21+/ mice (Figure 2D). In
azoxymethane (AOM)-induced adenomas, ApcWT LOH was
significantly reduced from 68.8% (22/32) to 34.3% (12/35) on a
Rad21+/ background (Figure 2D). Since the propensity forApcWT
LOH has been found to be usurped by other mechanisms (Møl-
lersen et al., 2004), the reduction in ApcWT LOH in AOM-induced
adenomas on aRad21+/ backgroundmay be due to a deficiency
in the pathways, such as HR, by which LOH arises.
To investigate whether the HR capability of intestinal cells was
altered on a Rad21+/ background, we evaluated the frequency
of sister chromatid exchange (SCE), a surrogate assay for HR, in
primary intestinal organoids following treatment with mitomycinhors
Figure 1. Ex Vivo ApcWT LOH Is Accelerated by DNA Damage and Associated with Extensive CIN
(A) Individual organoid-based RFLP assay used for the evaluation of theApcWT LOH. HindIII digestion of PCR products produces two fragments corresponding to
the WT and Min alleles.
(B) Percentage of ApcWT LOH in organoids. No LOH, ApcWT to ApcMin allelic ratio <1.2; LOH, ratio >1.2 and no WT band.
(C) gH2X foci (yellow arrowheads) and extensive DNA fragmentation (white arrowhead) in ApcMin/+ organoids treated with H2O2. Inset: enlarged view of the boxed
region.
(D) Percentage of diploid (2n), hypoploid (<2n), or hyperploid (>2n) cells in MEFs, primary and secondary cyst-like organoids, and cell cultures established from
ApcMin/+ adenomas (Ade).
(E) RepresentativeMEF cells showing abnormal mitoses: multipolar spindles (arrowheads), lagging chromosomes (arrows), anaphase bridges (open arrows), and
micronuclei (open arrowheads). Mitotic spindles were revealed by a-tubulin staining (green) and DNA by propidium iodide (red). Ana, anaphase.
(F) Percentage of abnormal mitoses in MEFs. Total mitotic cells scored: WT n = 399; Min: ApcMin/+ n = 388.
Data represent mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant. See also Figure S1 and Tables S1 and S2.C (MMC), DNA damage from which is repaired preferentially by
HR-dependent mechanisms (Sonoda et al., 1999). WTmouse in-
testinal cells had an average of 4.6 SCEs/metaphase. SCEswereCell Rereduced to an average of 3.8/metaphase in the double-mutant
ApcMin/+:Rad21+/ organoids; a statistically significant reduction
compared to ApcMin/+ organoids (Figure 2E).ports 9, 1781–1797, December 11, 2014 ª2014 The Authors 1783
Figure 2. Rad21 Haploinsufficiency Affects Survival, Adenoma Formation, ApcWT LOH, and CIN
(A) Immunofluorescence (IF) of Rad21 localization in small intestine (SI) and large intestine (LI, colon). Monochrome images in black and white. Rad21 (green) and
nuclear DNA (red) colocalization (yellow). Paneth cells, red arrows; mitotic cells, yellow arrows. Scale bars represent 20 mm.
(B) Kaplan-Meir survival plot of animals. WT n = 25; Rad21+/ n = 32; ApcMin/+ n = 51 ; ApcMin/+:Rad21+/ n = 30. Right: multiple adenomas throughout the
intestines (red arrows).
(C) Adenoma incidence at different murine ages.
(legend continued on next page)
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To ascertain the effect of Rad21 deficiency on HR, we em-
ployed a GFP-reporter assay, which allows for a more direct
measure of HR in vitro (Pierce et al., 1999). We generated
HCT116 cell clones with stable integration of an HR substrate
containing a mutated GFP (SceGFP) and an internal region of
GFP (iGFP; Figure 2F). The transient expression of I-Sce I endo-
nuclease induces aDSB site that is subsequently repaired via HR
using iGFP as a template, producing GFP+ cells (Figure 2F).
siRNA-mediated RAD21 depletion resulted in a significant
reduction in the frequency of GFP+ cells (Figure 2F), demon-
strating an essential role for RAD21 in mediating HR.
The effect of combined Rad21 heterozygous loss and ApcMin
mutations on CIN was investigated in MEFs and primary epithe-
lial organoids. ApcMin/+:Rad21+/ double mutants showed a
lower percentage of aneuploidy inMEFs (Figure 2G cf. Figure 1E;
Table S2), but not in primary organoid epithelial cells (Figure 2G;
Table S2). ApcMin/+:Rad21+/ double-mutant MEFs appeared to
have restored mitotic integrity to a level comparable to WT, with
a reduction in multipolar cells (Figure 2H). These data suggested
a possible interplay between Rad21 and Apc at the mitotic spin-
dle. RAD21was indeed detected atmitotic spindles, colocalizing
with a-tubulin in CRC cells (Figure 2I).
Rad21Heterozygous Deletion Reduces Lgr5 Expression
in ISCs and Compromises ISC Self-Renewal following
ApcWT LOH
ISC plays a critical role in adenomagenesis (Barker et al., 2009).
We investigated the effect of Rad21 heterozygous loss on ISC
gene expression and activity. The ISC population is enriched
for high aldehyde dehydrogenase (ALDH) activity, a functional
marker of stem/progenitor cells (Moreb, 2008). Among known
ISC markers, the expression of Lgr5 was significant reduced in
Rad21+/ ISCs, while the expression of Bmi1, Tert (telomerase
reverse transcriptase) and Sox9 (SRY box9) was not affected
(Figure 3A).
To assess the effect of Rad21 heterozygous deletion on ISC
self-renewal, the frequency of organoids formed from single
cells of primary SI organoids was used as a readout (Sato
et al., 2009). No statistically significant difference in the effi-
ciency of organoid formation was found among the four geno-
types (Figure 3B). When the self-renewal of cyst-like organoids
was assessed in view of our finding that the majority of cyst-
like organoids had completely lost the Apc WT allele (Fig-
ure 1B), ApcMin/+:Rad21+/ cyst-like organoids exhibited a
marked reduction in the efficiency of organoid formation
(Figure 3C).(D) Percentage of ApcWT LOH in organoids, adenomas (Ade), and AOM-induced
(E) MMC-induced SCEs in primary intestinal epithelial cells from organoid cult
(arrows) with an enlarged view of SCE (box).
(F) DR-GFP recombination assay in HCT116 cells. Left: diagrammatic representat
control cells. DF2, DharmaFECT 2 transfection reagent. Right: western blot valid
(G) The percentage of diploid (2n), hypoploid (<2n), or hyperploid (>2n) cells in M
(H) Percentage of abnormal mitoses in MEFs. Total mitotic cells scored: Rad21+
chromosome(s); Ana, anaphase.
(I) IF of LIM1215 colon cancer cells. RAD21 (green) and a-tubulin (blue) colocali
ApcMin/+; Double, Rad21+/:ApcMin/+ double mutant.
Data represent mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significa
Cell ReRad21 Heterozygous Loss Alters Gene Expression
on a Global Scale
To identify genes whose expression is affected by Rad21 hap-
loinsufficiency, we compared the gene expression profiles of
crypt epithelial cells and adenomas from ApcMin/+ and ApcMin/+:
Rad21+/ double-mutant mice by RNA sequencing (RNA-seq).
Gene expression profiles of crypts from ApcMin/+ and ApcMin/+:
Rad21+/ mice are likely to represent the transition from normal
to the early stage of adenomagenesis, given that there were
>50% mapped sequence reads corresponding to the mutant
allele of the Apc gene (Figure S3A). Hierarchical clustering iden-
tified genes associated with Rad21 heterozygosity (Figure 3D).
This was more evident in crypts than adenomas. We reasoned
that the effect of Rad21 heterozygous loss on gene expression
may have been attenuated by the upregulation of Rad21 expres-
sion in adenomas. Quantitative RT-PCR (qRT-PCR) confirmed
that the steady-state level of Rad21 transcripts was not signifi-
cantly altered in ApcMin/+:Rad21+/ adenomas compared to
ApcMin/+ adenomas (Figure 3E). By contrast, the level of Rad21
transcripts was significantly reduced in crypts of ApcMin/+:
Rad21+/ double mutants (Figure 3E). Interrogation of gene
expression profiles of crypts between ApcMin/+ single and
ApcMin/+:Rad21+/ double mutants identified 3,869 genes that
showed significantly altered expression on a Rad21+/ back-
ground, of which 55 genes showed changes greater than 4-
fold (Table S4). qRT-PCR verified the changes in the expression
of several affected candidate genes including upregulated genes
Akap12 (A kinase anchoring protein 12) and homeobox-contain-
ing transcription factor Hoxb9, and downregulated genes
mannan-binding lectin Mbl2, Sparc 1 (secreted protein, acidic,
cysteine-rich glycoprotein), and a member of cytochrome P450
(CYP) mono-oxygenases, Cyp1a2 (Figure 3F). Genes with
altered expression between ApcMin/+ and ApcMin/+:Rad21+/
crypts were significantly enriched for functions such as mitotic
checkpoint, chromosome condensation, DNA damage check-
point, and apoptosis (Figure 3G). Comparison of gene expres-
sion profiles between adenomas from ApcMin/+ single- and
ApcMin/+:Rad21+/ double-mutant mice showed relatively mod-
est changes. Among 601 genes with significantly altered expres-
sion, only 63 genes showed changes greater than 2-fold (Table
S5). The altered expression of genes such as Abpa (amylase-
binding protein A), DNase I (deoxyribonuclease I), and Mcpt9
(mast cell protease 9) was validated by qRT-PCR (Figure 3H).
Rad21 heterozygosity also affected the expression of Wnt
target genes, with genes such as Axin2, gastrin, andWnt4 being
significantly downregulated but not for genes such as c-Myc andadenomas.
ures. Insert: a representative metaphase chromosome spread showing SCE
ion of the assay. Middle: percentage of GFP-positive cells in siRNA treated and
ation of RAD21 KD; actin, loading control.
EFs and primary organoids.
/ n = 280; ApcMin/+ n = 388; Rad21+/:ApcMin/+ double mutant n = 395; Chr,
zation (light blue) on the mitotic spindle in the merged image; DNA (red). Min:
nt. See also Figures S1 and S2 and Tables S1–S3.
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Figure 3. The Effect of Rad21 Heterozygosity on Intestinal Stem Cell Gene Expression and Self-Renewal
(A) qRT-PCR of intestinal stem cell (ISC) marker gene expression inWT and Rad21+/ ALDH+ cells. Expression was normalized to b2M. WT n = 3; Rad21+/ n = 4.
(B) Organoid self-renewal assay for stem cell activity. WT n = 7; Rad21+/ n = 3; ApcMin/+ n = 4; Double n = 4.
(C) Cyst-like organoid self-renewal. ApcMin/+ n = 3; Double n = 8.
(D) Heatmaps of representative gene clusters showing selected up- (top) and downregulated (bottom) genes associated withRad21 heterozygosity. Log2FC, log2
fold change.
(E) qRT-PCR ofRad21 expression in SI crypts and adenomas. Right: WT n = 4; ApcMin/+ adenomas n = 7. Left: ApcMin/+ crypts n = 6; Double crypts n = 7,ApcMin/+
adenomas n = 4; Double adenomas n = 4.
(legend continued on next page)
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Wnt3 (Figures S3B and S3C). Hierarchical analysis for an ex-
panded list of known Wnt/b-catenin target genes identified clus-
ters that are unique to ApcMin/+:Rad21+/ double-mutant crypts
and, furthermore, revealed that the Wnt gene expression profile
of double-mutant crypts are more closely related to WT than
ApcMin/+ crypts (Figure S3D). The analysis clustered ApcMin/+:
Rad21+/ adenomas with ApcMin/+ adenomas (Figure S3D).
Elevated Rad21 Expression in Adenomagenesis Is
Uncoupled from Proliferation
We performed immunostaining to determine when and where
elevated Rad21 expression occurs during adenomagenesis in
bothApcMin/+mice and human sporadic CRCs. Elevated but het-
erogeneous Rad21 staining was evident in cyst-like organoids,
aberrant crypt foci (ACF), and adenomas of ApcMin/+ mice (Fig-
ure 4A). RAD21 expression was elevated in five out of ten human
CRC cell lines examined compared to the human embryonic
kidney 293 (HEK293) cell line (Figure 4B). Immunostaining con-
firmed that RAD21 is predominantly nuclear (Figure 4C), as
seen in other cancer cells (Xu et al., 2004).
To examine the association of RAD21 expression with prolifer-
ation, we performed coimmunostaining of RAD21 in normal co-
lon with a proliferation marker Ki-67, since human colon, not
SI, is the primary site of GI cancer. RAD21 was detected in
80% of crypt epithelial cells (Figures 4D and 4E). At the bottom
and middle proliferative regions of crypts, approximately one-
third of RAD21+ cells colocalized with Ki-67, whereas at the
upper region, the majority of cells were positive only for RAD21
(Figures 4D and 4E). In adenomas, RAD21 staining was observed
in nearly all cells (Figures 4D and 4E). There was a statistically
significant increase in RAD21/Ki-67 double-positive cells
(28.2% ± 2.4%) compared to normal crypts (19.9% ± 1.3%;
p = 0.0038) and, furthermore, unlike in normal crypts, double-
positive cells were observed along the entire length of crypts
(Figures 4D and 4E). RAD21 and Ki-67 staining was similar in ad-
enocarcinomas (Figure 4E). A similar pattern of Rad21/Ki-67
staining was observed in ApcMin/+ mouse adenomas (Fig-
ure S4A). Rad21 staining in mouse adenomas appeared to be
more heterogeneous compared to human polyps and CRC,
possibly since mouse adenomas are generally early stage.
To directly assess the effect of elevated RAD21 expression on
cell proliferation and cell-cycle progression, we overexpressed
RAD21 in SW480 cells (Figure S4B). No difference in proliferation
and cell-cycle progression was observed between RAD21-over-
expressing and control cells (Figures 4F and S4C).
RAD21 Is Regulated by b-Catenin Activation and Tracks
with Aberrant b-Catenin Localization in Adenomas
Elevated Rad21 expression appeared to coincide with the
activation of the Wnt/b-catenin pathway, as indicated by the
aberrant subcellular (nuclear or loss of membrane) location of
b-catenin (Figure 5A). We thus tested whether Rad21 was a(F) qRT-PCR validation of gene expression changes in ApcMin/+ crypts compared
(G) Top ten pathways with gene expression altered by Rad21 heterozygosity.
(H) qRT-PCR validation of gene expression changes inApcMin/+ and double-mutan
Double: Rad21+/:ApcMin/+ double mutant.
Data represent mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; n
Cell Redirect b-catenin transcriptional target gene. Cotransfection of
the Rad21-promoter-chloramphenicol acetyl-transferase (CAT)
reporter with increasing activated (D89)-b-catenin levels showed
the induction of the CAT reporter in a dose-dependent manner
(Figure 5B). An examination of the 4 kb 50 upstream of the
Rad21 proximal promoter identified seven putative high-affinity
binding sites for Tcf7L2/Tcf4 (T cell binding factor), which com-
bines with b-catenin to activate the canonical Wnt signaling.
These putative motifs are located in two clusters: one at the
proximal region (200 to500 bp) and the other within the distal
region of 3,600 to 3,800 bp (Figure 5C). Chromatin immuno-
precipitation-quantitative PCR (ChIP-qPCR) confirmed an
enrichment of b-catenin at these regions compared to a control
region lacking the motifs (Figure 5C).
Consistent with our mouse data, elevated RAD21 expression
was clearly evident in CRC and coincided with aberrant b-cate-
nin localization (Figure 5D). Tissue microarrays (TMAs) assem-
bled from two large independent CRC patient cohorts (total of
529 sporadic cases) were examined for RAD21 and b-catenin
staining. CRC samples showed variable RAD21 protein staining,
ranging from negligible to very strong (Figure 5E). The mean his-
toscore, a combination of the intensity and percentage of posi-
tive cells, of RAD21 is significantly higher in tumors with aberrant
b-catenin localization compared to those with normal membra-
nous localization (9.27 versus 7.88 [p = 0.004] in the first cohort
and 6.0 versus 5.2 [p = 0.04] in the second cohort). In both co-
horts, tumors exhibiting a high level of RAD21 expression (i.e.,
histoscore 12) were more frequent in aberrant b-catenin groups
(Figure 5E; Table S6). This was particularly evident in cohort 1,
with 40 out of 84 (47.6%) cases in the aberrant group compared
to 30 out of 124 (24%) cases in the normal group (Figure 5E;
Table S6). These data suggest that, as in the Apcmin/+ mouse
model, RAD21 expression is upregulated by Wnt/b-catenin acti-
vation in human CRC.
To directly assess the effect of the Wnt activation on RAD21
expression, we blocked the Wnt signaling by either enforced
expression of a dominant-negative TCF4 (dnTCF4) gene or
ectopically expression of the WT APC gene (Faux et al., 2004).
RAD21 expression was significantly reduced in both cases
(Figure 5F).
Genome-wide Analysis Identifies Rad21 as a Key
Regulator of CRC Genes
To identify genes that are directly regulated by Rad21, we per-
formed genome-wide mapping of Rad21 binding sites with
ChIP sequencing (ChIP-seq) (Johnson et al., 2007). This analysis
identified high confidence Rad21-occupied regions correspond-
ing to sites unique to, or shared between, normal SI crypts and in
ApcMin/+ adenomas (Figures 6A and 6B). Consistently, Rad21
binding sites were found at gene loci known to be associated
with Rad21, as exemplified by the Hox (homeobox) gene family
(Schaaf et al., 2013) (Figure S5A).to double-mutant crypts. ApcMin/+ crypts n = 3; Double crypts n = 3.
t adenomas.ApcMin/+ adenomas n = 4; Double adenomas n = 4. Min: ApcMin/+;
s, not significant. See also Figure S3 and Tables S4 and S5.
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Figure 4. Elevated Rad21 Expression in Mouse and Human Adenomagenesis Is Uncoupled from Proliferation
(A) Immunofluorescence (IF) of Rad21 expression in ApcMin/+ mouse organoids (top), ACF (middle), and adenomas (bottom). Monochrome images in black and
white. Rad21 (green) and nuclear DNA (red) colocalization (yellow). Some nuclei (red arrows) showed a stronger Rad21 signal.
(legend continued on next page)
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Rad21 was found to be enriched at the core promoters of
known Wnt/b-catenin target genes in adenomas (eg, Lgr5; Fig-
ure 6C). The enrichment at the Lgr5 promoter was independently
confirmed by conventional ChIP (Figure 6C). The association of
Rad21 with the promoters of two archetypical Wnt target genes,
c-Myc andCcnd1, was observed and confirmed by conventional
ChIP (Figures S5B–S5D), noting that c-Myc is a known cohesin-
regulated gene (Rhodes et al., 2010). Rad21 enrichment was
also detected at the core promoter of cohesin gene SMC3 (Fig-
ure 5D), suggesting that cohesin gene expression is autoregu-
lated. As a negative control, we used conventional ChIP-qPCR
to confirm that low Rad21 binding regions have nonsignificant
Rad21 binding (Figure 6E). Collectively, these data suggest a co-
ordinated transcriptional activation program that is regulated by
Rad21 following ApcWT LOH.
Rad21 Is Enriched in the Regulatory Regions L1
Retrotransposons
We scanned the Rad21-associated sequences for the presence
of retrotransposons in ChIP-seq data sets. The analysis identi-
fied an enrichment of retrotransposons within high-confidence
Rad21 binding regions in both crypt cells and ApcMin/+ ade-
nomas. These included short interspersed elements (SINEs),
L1 and long terminal repeat (LTR) retrotransposons (Figure S6A).
Since L1 is the most abundant and the only retrotransposon
capable of autonomous retrotransposition in the mammalian
genome, we performed a more detailed analysis on L1. L1
expression, which coincided with elevated Rad21 expression,
was detected in mouse adenomas (Figure S6B). Rad21 enrich-
ment was found at the internal promoter within the L1 50 UTR tan-
dem repeats (Figures 7A and 7B). Since the mouse L1 promoter
is rich in CpG repeats, we used a methylation-sensitive enzyme
(HpaII) digestion to determine whether Rad21 binding was influ-
enced by themethylation status. Rad21-associated L1 promoter
sequences amplified from both crypts and adenomas were fully
digested by HpaII (Figures 7C and S6C), suggesting the absence
of methylation. CTCF, a chromatin insulator and known Rad21
interactor, was also present at the L1 promoter sequences
bound by Rad21 at representative loci corresponding to full-
length L1 (Figure 7D).
RAD21 Drives L1 Expression in Human CRC Cell Lines
An examination of a panel of ten human CRC cell lines revealed
strongly correlated expression between L1 and RAD21 (Fig-
ure S6D). Likewise, the levels of L1 proteins, ORF1p and
ORF2p, coincided with the abundance of RAD21 protein (Fig-(B) qRT-PCR of RAD21 expression in a panel of human CRC cell lines. Expres
HEK293. *p < 0.05.
(C) IF of RAD21 in LIM1215 cells showing predominant nuclear localization in int
(D) Co-IF of RAD21 and proliferation marker Ki-67 in human normal crypts (top),
black and white. RAD21 (red) and Ki-67 (green) colocalization (yellow) in merge
located between dysplastic crypts (middle).
(E) Quantitation of data shown in (D). Left: a representative normal crypt showin
upper (U). Data represent the mean of ten normal crypts (n = 2,184 nuclei), five
carcinomas (n = 8,802 nuclei). AC, adenocarcinomas.
(F) Proliferation of the SW480 cell clone with stable enforced RAD21 expression
independent experiments.
See also Figure S4.
Cell Reure 7E). An apparent reduction in the levels of endogenous L1
protein was observed in LIM1215 cells following RAD21 knock-
down (KD) by either siRNA or stable expression of small hairpin
RNA (shRNA; Figure 7F), suggesting a close association be-
tween RAD21 and L1.
To directly assess the effect of RAD21 on L1 expression, we
introduced a construct containing the human L1 50 UTR (pro-
moter) driven GFP reporter gene under into HCT116 p53/
cells. Stable GFP-expressing cells were obtained in cells with
enforced RAD21 expression (Figures 7G and S6F). L1-GFP
signal appeared stronger in cell doublets (mitotic cells; Fig-
ure 7G), correlating with RAD21 expression (Figure S6F). To
ascertain that L1-GFP expression was RAD21 dependent, we
assessed GFP expression following siRNA-mediated RAD21
KD. GFP signal was reduced or completely lost in some cells
(Figure 7H). This phenotype was not observed in control cells
transfected with mock siRNA (Figure 7H). Western blot further
confirmed a reduction in GFP protein in siRNA KD cells
compared to the mock-siRNA control (Figure 7H).
L1 Expression Associates with Elevated RAD21 in
Human Adenomas and CRC
To address the relationship between RAD21 and L1 expression
in human CRC, we evaluated the expression of both proteins
in adenocarcinomas. L1 was barely detectable in normal crypts
but clearly evident in the cytoplasm and, in some cases, nuclei of
adenocarcinomas (Figure 7I). Because the retrotransposition of
L1 takes place in the nucleus, the presence of nuclear L1 is indic-
ative of retrotransposon activities. Strong RAD21 staining was
detected in cells that are positive for L1 staining (Figure 7I). Ex-
amination of L1 expression in TMAs consisted of 142 adenocar-
cinomas showed a statistically significant association between
elevated RAD21 and L1 expression (Figure 7J). These data sug-
gest that L1 activation is an early event in CRC development and
that RAD21 is a probable regulator of L1 expression.
DISCUSSION
The ApcMin/+mouse model affords the opportunity to investigate
the earliest events in the development of CRC and it is remark-
able how many of the requisite events are influenced by cohesin
function. Here, we show that Rad21 haploinsufficiency affects
the initiating events of adenomagenesis in ApcMin/+ mice.
Further, we found thatRad21 is a direct Wnt pathway target con-
necting the elevated expression of Rad21 with aberrant b-cate-
nin localization. Finally, our genome-wide analysis revealed a keysion was normalized to the PGK gene and fold change calculated relative to
erphase cells.
adenomas (middle), and adenocarcinomas (bottom). Monochrome images in
d images. Note the intense staining of both RAD21 and Ki-67 in lymphocytes
g the partitioning of three crypt compartments: bottom (Bt), middle (Mid), and
polyps (n = 6,135 nuclei), and ten random microscopy fields (403) of adeno-
compared to the vector control clone. Data represent mean ± SEM of three
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Figure 5. RAD21 Expression Tracks with Aberrant b-Catenin Localization during Adenomagenesis and Is a Direct b-Catenin Target Gene
(A) Co-IF of Rad21 and b-catenin in ApcMin/+ adenomas. Monochrome images in black and white. Rad21 (red) and b-catenin (green) colocalization (yellow). Note
the apparent colocalization of aberrant nuclear b-catenin staining with enhanced Rad21 signal in some regions (red circle and arrow).
(B) CAT reporter assay showing transactivation of the mouse Rad21 promoter by increasing activated b-catenin. Data represent mean ± SEM of three inde-
pendent experiments.
(legend continued on next page)
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role for Rad21 in global gene transcription and particularly in the
expression of L1 retrotransposons. Our study of human sporadic
CRC recapitulated these findings, supporting a role for RAD21 in
the initiation and progression of human CRC through multiple
mechanisms.
Rad21 Is a Key Mediator of ApcWT LOH
ApcWT LOH is frequently observed in human FAP (Spirio et al.,
1998) and sporadic CRC (Clevers and Nusse, 2012; Cottrell
et al., 1992), leading to the suggestion that this is an initiating event
in CRC. A number of mechanisms for the genesis of LOH have
beenproposed (Caldwell et al., 2007; Dikovskaya et al., 2007; Hai-
gis and Dove, 2003; Moynahan and Jasin, 2010). These include
gene conversion via HR (Haigis and Dove, 2003; Moynahan and
Jasin, 2010) and whole-chromosome gain or loss due to mitotic
defects (Caldwell et al., 2007; Dikovskaya et al., 2007). We
demonstrated thatApcWTLOHcanbeaccelerated in vitro through
the induction of oxidative DNA damage. Our data suggest that
DNA damage and, presumably, its subsequent repair contribute
to ApcWT LOH, supporting a role for HR in mediating LOH.
Our study revealed that Rad21 haploinsufficiency led to a sig-
nificant reduction in ApcWT LOH, providing evidence that Rad21
is a critical factor in mediating this event. We suggest that Rad21
contributes to this event primarily through its role in HR. Our find-
ings that Rad21 haploinsufficiency led to a significant decrease
in the frequency of SCEs and that siRNA KD of RAD21 impeded
HR provide compelling evidence supporting a role for Rad21 in
HR-mediated ApcWT LOH.
Increased CIN Is Evident in De Novo Adenoma and
Associated with ApcWT LOH
Cell-based and intestinal crypt studies indicate that the first his-
tologically discernible step toward CIN in Apc mutant cells in-
volves mitotic spindle misorientation (Fleming et al., 2009) and
subsequent tetraploidy (Caldwell et al., 2007; Dikovskaya
et al., 2007). Although CIN tracks closely with LOH of the Apc
gene, the interplay between these events is not well understood.
Our results show that although chromosomal numerical aberra-
tions of primary ApcMin/+ MEFs were high and concordant with
an abnormal, largely hyperploid complement, there is no evi-
dence of increased CIN in ApcMin/+ primary epithelial cells of or-
ganoids, even though LOH was present. There is, however, a
marked increase in CIN in cyst-like organoids. Thus, the increase
in CIN coincides with completed ApcWT LOH in these cells and
that ApcWT LOH appears to precede CIN.
Our data further revealed that Rad21 heterozygosity reduces
CIN in ApcMin/+ cells in MEFs and primary organoids. How(C) ChIP-qPCR showing the enrichment of b-catenin binding at themouseRad21 5
Tcf4 binding motifs (red bars) compared to a negative control region lacking the
assays.
(D) Representative images of human CRC TMAs showing weak (arrows, top left) an
Adjacent sections were appraised for either membranous only (normal) or aberra
(E) Correlation of normal b-catenin membrane or aberrant localization with RAD
cohort 2 n = 323). RAD21 histoscore (0–12); A, aberrant localization; N, normal m
(F) qRT-PCR of RAD21 expression in SW480 cells showing reduced RAD21 expr
APC expression.
Data representmean ±SEM of six independent transient transfections for dnTCF4
***p < 0.001. See also Figure S3 and Table S6.
Cell ReRad21 haploinsufficiency restores this abnormality is at present
unclear. ApcMin/+:Rad21+/mutant cells had a significant reduc-
tion in the multipolar type of abnormal mitoses implies a func-
tional crosstalk between APC and RAD21 at mitotic spindles.
Consistent with this notion, APC has been shown to be localized
at the mitotic spindle apparatus (Fleming et al., 2009) and the
ApcMinmutation impairs the spindle checkpoint through its inter-
action with Mad2 (Zhang et al., 2009). Likewise, we and others
found that RAD21 and SMC1 are localized at mitotic spindles
(Wong and Blobel, 2008). Furthermore, cohesin was shown to
be recruited to the spindle poles by nuclear mitotic apparatus
protein (NuMA) (Kong et al., 2009). We suggest that Rad21 defi-
ciency may directly or indirectly antagonize this effect by
restoring the spindle checkpoint, leading to the elimination of
aberrant mitotic cells that would otherwise have given rise to
aneuploid cells.
Effects of Rad21 Overexpression Are Uncoupled from
Proliferation
Could the modulation of Rad21 expression and the myriad of
consequences on adenomagenesis be due to a direct role of
Rad21 in regulating proliferation? Biological data from analysis
of Rad21 heterozygous GI crypt proliferation suggested that
this was unlikely (Xu et al., 2010). Furthermore, we found non-
concordance of Ki-67 and Rad21/RAD21 expression in mouse
and human crypts, adenomas, and carcinomas. Enforced
RAD21 expression did not affect proliferation and cell-cycle pro-
gression in SW480 cells. We thus conclude that Rad21mediates
its many effects by processes independent of proliferation.
Genes that regulate cell cycle were substantially affected in
ApcMin/+ crypts by Rad21 haploinsufficiency in our RNA-seq an-
alyses. This effect maybe an indirect consequence of Rad21
deficiency, for example, delayed S phase progression (Guillou
et al., 2010), impaired spindle assembly (Kong et al., 2009), or
altered chromosome architecture (Zuin et al., 2014). Additionally,
these changes in gene expression may reflect a global transcrip-
tional change at the very early stages of adenomagenesis.
Upregulation of Rad21 viaWnt/b-Catenin Activation Is
an Early Event in CRC
RAD21 upregulation occurs in approximately half of human
CRCs (Deb et al., 2014). We found that elevated RAD21 expres-
sion occurs at the early stages of carcinogenesis. How RAD21
expression is upregulated in CRC is unknown. RAD21 upregula-
tion was shown to be associated with gene amplification in high-
grade breast cancer (Xu et al., 2011b) and with c-Myc gene
amplification in CRC (Deb et al., 2014). Since the RAD21 gene0 upstream regions (red, gray, and blue boxes) that contain high-affinity Tcf7L2/
motif (F2, open box). Data represent mean ± SEM of three independent ChIP
d strong (top right) RAD21 nuclear staining and aberrant b-catenin localization.
nt b-catenin staining.
21 expression in two independent cohorts of human CRCs (cohort 1 n = 206;
embrane staining.
ession following either transient expression of dnTCF4 or the restoration of WT
and three independent harvests of SW480+WTAPC cells. *p < 0.05; **p < 0.01;
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Figure 6. Rad21 Binds to Key CRC Genes in ApcMin/+ Adenomas
(A) Venn diagram showing the distribution of unique and shared Rad21 binding sites.
(B) Pie charts showing the percentage of high-confidence Rad21 binding regions at gene transcriptional start sites (TSS), 50 or 30 UTR exons, coding exons,
introns, and intergenic regions.
(legend continued on next page)
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locates at 8q24, a region that encompasses c-Myc and
commonly amplified in epithelial cancers, RAD21 overexpres-
sion may simply be consequence gene amplification at 8q24.
Our data that elevated Rad21 expression associated with
aberrant b-catenin subcellular location in intestinal tumors raise
the further possibility that Rad21 upregulation occurs through
Wnt/b-catenin signaling. b-Catenin binds to the Rad21 promoter
and is capable of driving Rad21-CAT reporter expression.
Furthermore, RAD21 expression in human CRC cells was
directly modulated by Wnt/b-catenin activation, in that RAD21
expression was found to be significantly reduced when Wnt/
b-catenin signaling was blocked. Upregulation of Rad21 expres-
sion via aberrant Wnt/b-catenin activation seems to be an early
event in human CRC.
Rad21 Positively Regulates the Expression of GI Stem
Cell and CRC Genes
Our genome-wide analysis revealed the association of Rad21
with the core promoters/transcription start sites (TSSs) of
approximately 5%–12% of genes, while the majority of Rad21
binding sites mapped to intergenic or intronic regions. This is
consistent with the known role for cohesin in regulating tran-
scription, either by direct interaction with Pol II transcriptional
machinery through the mediator complex (Kagey et al., 2010)
or by organizing chromatin structure (Zuin et al., 2014).
Rad21 associates with the core promoters/TSSs of known key
stem cell markers andWnt target genes that are critical for CRC.
Of particular interest is the association of Rad21 with the Lgr5
ISC gene. This association appears to have a direct and positive
role for Rad21 in regulating Lgr5, since a specific reduction of
Lgr5mRNAwas observed inRad21+/ animals. Further, this reg-
ulatory role of Rad21 for Lgr5 is likely to be functionally signifi-
cant in that it affects ISC activity. Although the self-renewal of
primary organoids was unaffected by Rad21 heterozygosity,
our previous in vivo assay showed that ISC potential was
compromised by Rad21 haploinsufficiency following ionizing ra-
diation (Xu et al., 2010). Importantly, we found that the self-
renewal of cyst-like organoids was severely compromised by
Rad21 heterozygosity. In view of our data that the majority of
cyst-like organoids had already lost the WT Apc allele, the effect
of Rad21 haploinsufficiency on ISC activity is likely to be Wnt
dependent. Furthermore, Rad21 expression in Paneth cells is
likely to affect the interdigitated Lgr5+ ISCs, since Paneth cells
are essential components of the ISC niche and their deletion re-
sulted in the loss of Lgr5+ cells (Akcora et al., 2013; Sato et al.,
2011). This is, however, likely to be indirect, possibly through
Wnt signaling, as it is at its strongest in Paneth cells (van Es
et al., 2005). Since Lgr5+ stem cell-specific loss of Apc (i.e.,
the activation of Wnt signaling) was shown to be essential for
the initiation and progression of adenomagenesis (Barker et al.,
2009), our findings support an interplay between Rad21 and
Lgr5 in the early stage of adenomagenesis in the context of(C) Enrichment for Rad21 at the 50 upstream regions (blue boxed regions) and T
revealed by ChIP-seq. Left: relative Rad21 enrichment confirmed by ChIP-qPCR
(D) Rad21 enrichment at the upstream and TSS of the cohesin Smc3 gene.
(E) A negative control region on chromosome 17 showing no Rad21 enrichment.
ChIP-qPCR data represent mean ± SEM of three independent ChIP assays. *p <
Cell ReWnt signaling. Our data that Rad21 associates with the pro-
moters of multiple Wnt target genes further support a direct reg-
ulatory role for Rad21 in theWnt signaling pathway, which in turn
promotes neoplastic transformation.
Rad21 Association with Retrotransposons as a
Mechanism for Inducing Genomic Instability and
Transcriptional Dysregulation in Adenomas
Retrotransposons are mobile genetic elements that are potent
endogenous mutagens and are kept in an inactive state. The
transcription of retrotransposons and the subsequent insertion,
primarily with L1, into new sites has been reported in human can-
cers and can lead to disruption of TSGs (Lee et al., 2012), activa-
tion of proto-oncogenes (Nigumann et al., 2002), as well as the
genesis of large genomic rearrangements (Mazoyer, 2005). Our
ChIP-seq analysis provides evidence that Rad21 and/or cohesin
is an important regulator of these repetitive mobile DNA se-
quences, in particular L1. We found that RAD21 expression
directly affects the L1-promoter activity in vitro and that Rad21
association with the L1 promoter is independent of methylation,
a known mechanism controlling the L1 activity (Iskow et al.,
2010). We thus propose that Rad21 and/or cohesin exerts both
direct and indirect effects on the L1 activities, by either directly
driving L1 expression, or by mediating the formation of chro-
matin loops.
Our data revealed a strong association between L1 expression
and elevated RAD21 expression in human CRCs, implicating
RAD21-mediated L1 expression in CRC carcinogenesis and
prognosis. L1-encoded reverse transcriptase activity is impli-
cated in driving cellular transformation (Patnala et al., 2014).
RAD21-mediated L1 expression might contribute to this pro-
cess. The ability of L1 transcripts in autonomous retrotransposi-
tion could potentially lead to the disruption of gene expression in
CRCs that have been shown to have the highest frequency of L1
somatic insertions (Lee et al., 2012). Another possible conse-
quence for RAD21-L1 interaction is in inducing CIN. Retrotrans-
posons, once transcriptionally unsilenced, are then freed to
mobilize throughout the genome and engage in HR, both locally
and globally (Iskow et al., 2010; Nigumann et al., 2002). Such ille-
gitimate recombination events between repetitive elements
spanning the genome are likely to serve CIN. Elevated RAD21
expression may promote hyperrecombination of such repetitive
elements. Finally, L1 promoter methylation was reported to be a
potential prognostic marker in gastrointestinal cancer (Baba
et al., 2014). In view of our finding that Rad21-mediated L1
expression is independent of L1methylation, it would be of inter-
est to evaluate the prognostic value of L1 expression in the
context of Rad21 expression.
Role of Cohesin in Tumorigenesis
We propose that Rad21 contributes to the early events that are
essential for the initiation and progression of adenomas throughSS (red boxed region) of the Lgr5 gene. Left: Rad21 enrichment in adenomas
.
0.05; ns, not significant. See also Figure S5.
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Figure 7. Rad21Binding to L1Retrotransposon 50 UTRRegions inApcMin/+Adenomas and Its Activated Expression in HumanCRCCell Lines,
Sporadic Adenomas, and CRC
(A) Enriched (boxed regions) Rad21 binding to the internal promoter within the 50 UTR tandem repeats of L1. Ade, adenomas.
(B) ChIP-qPCR showing increased Rad21 binding in the 50 UTR of L1 elements. Data represent mean ± SEM of three independent ChIP assays. *p < 0.05.
(legend continued on next page)
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multiple mechanisms. Our findings suggest RAD21 as a driver of
an insidious cycle of genomic instability, first through promoting
Apc LOH, which in turn upregulates Rad21 expression, which
further drives global genomic instability via the Wnt signaling
pathway and retrotransposon activation. These mechanisms
are not inherently restricted to intestinal carcinogenesis, and
the findings of this study raise a number of questions as to the
broader implications of cohesin dysregulation in other human
cancers.
EXPERIMENTAL PROCEDURES
Mice and Cell Lines
ApcMin/+mice (Moser et al., 1992) were crossed with Rad21+/mice (Xu et al.,
2010) on a C57BL/6J background under specific-pathogen-free conditions. All
experiments were conducted with approvals by the Institutional Animal Ethics
committee (E389 and E470). Human CRC cell lines and cell culture conditions
are described in the Supplemental Experimental Procedures.
Organoid Culture
Primary organoids were established from isolated SI crypts as described pre-
viously (Sato et al., 2009; Xu et al., 2010). To establish secondary organoid cul-
tures, primary organoids were disaggregated to single cells and reseeded in
Matrigel containing Rho-kinase inhibitor (Y-27632; Sigma-Aldrich).
Apc LOH Assay
Individual organoids were picked from primary cultures, and PCR products
were digested with Hind III (Promega) and separated on 10% polyacrylamide
gels (Amrasco). Signal intensity wasmeasured using Image One software (Bio-
Rad).
Mitoses, Chromosome Spreads, and SCEs
Mitosis, aneuploidy, and SCE were scored essentially as described previously
(Xu et al., 2010). For SCEs, bromodeoxyuridine (BrdU) was added at 5 mM for
48 hr and MMC at 6 mM for 30 min prior to the addition of Colcemid.
DR-GFP Recombination Assay
HCT116 cells were transfected with DR-GFPDNA and selected for puromycin-
resistant clones. A total of 20 mM of RAD21 siRNA (SMARTpool ON-Target
Plus) was delivered using DharmaFECT 2 (DF2; GE Healthcare Dharmacon).
Controls are cells treated with either Opti-MEM or mock transfected without
siRNA. Cells were analyzed 48 hr after pCbASce transfection with a FACS
Diva II (BD Biosciences). Data from two independent experiments, each with
three independent transfections, were analyzed using Flowlogic software.
qRT-PCR
qRT-PCR was performed using SYBG master mix (Applied Biosystems), and
primers are listed in Table S7. Each data point represents a minimum of three
animals per genotype and three independent harvests for human cell lines.(C) L1 promoter methylation analysis of a 300 bp fragment encompassing Cp
digestion indicates unmethylated DNA. DNA from two independent Rad21 ChIP
(D) PCR showing Rad21 and CTCF colocalization at individual L1 loci.
(E) Western blots of L1 and RAD21 expression in human CRC cell lines. L1 mRN
(F) Western blots showing an apparent reduction in L1 expression following siRN
(G) Stable L1-GFP expression in HCT116 cells with enforced RAD21 expression a
signal in doublets (arrows).
(H) The effect of L1-GFP expression following siRNA knockdown of RAD21 in HC
cases, GFP signal is mostly lost (arrows). Identical exposures for GFP images. L
(I) IF of RAD21 (top) and L1 (bottom) on adjacent sections. Monochrome images
merged images. RAD21 staining is homogenous and predominantly nuclear. L1 e
arrows).
(J) Cytoplasmic or nuclear L1 expression corresponds to elevated RAD21 expre
See also Figure S6.
Cell ReImmunofluorescence and Immunohistochemistry
Immunofluorescence of cells was performed as described previously (Xu et al.,
2004) on paraffin-embedded sections following irradiation with a UV transillu-
minator. IHC was performed as described previously (Xu et al., 2011b). CRC
ethic approvals were CO2.216 (Oxford cohort) and St Vincent’s Hospital
HREC H00/022 (Sydney cohort). CRC cases were assembled as TMA with
duplicate tumor cores per case.
Cell Cycle and Proliferation
Cells were pulse-labeled with 5 mM BrdU (Sigma-Aldrich) and stained with
anti-BrdU (BD Biosciences) (Deardorff et al., 2012). Flow cytometry used a
FACS Diva II (BD Biosciences). Cell-cycle profiles were analyzed using Flow-
logic software. Cell proliferation assays were done as described previously (Xu
et al., 2011b).
Human L1-GFP Expression Analysis
The 1.35 kb human L1 50 UTR-enhanced GFP construct was transfected
into HCT116 p53/ cells. GFP-positive cells were sorted to 99% purity us-
ing fluorescence-activated cell sorting. Cells were imaged using an in-
verted microscope (Leica) or harvested for protein analysis following siRNA
delivery.
RNA-Seq and ChIP-Seq
For RNA-seq, 50 bp pair-end sequencing was performed on the Hi-seq 2500
system (Illumina). ChIP was carried out using a ChIP validated rabbit anti-
Rad21 (Ab992, Abcam) and 50 bp single-end sequencing performed on the
Hi-seq 2000 system (Illumina). Short reads were mapped to mouse genome
reference UCSC MM9. Data analyses are described in the Supplemental
Experimental Procedures.
L1 Promoter Methylation Analysis by HpaII Restriction Digestion
DNA corresponding to either240 bpmouse L1 50 UTR tandem repeats or the
50 UTR of individual L1 loci were amplified by PCR following Rad21 ChIP and
digested with HpaII (Promega). Primers are listed in Table S8.
ALDEFLUOR Assay
Single-cell suspensions from SI crypts were stained using ALDEFLUOR stem
cell detection kit (STEMCELL Technologies) and sorted with FACS Diva (BD
Biosciences).
Statistical Analyses
Kaplan-Meier survival curves were compared using the log rank test. Fisher’s
exact test was performed for adenoma frequency, LOH and aneuploidy using
R software version 2.15.0 (http://www.r-project.org). Student’s t test was per-
formed for all other analyses.
ACCESSION NUMBERS
Data sets were deposited to the NCBI Gene Expression Omnibus under the
accession number GSE59283.G islands at the 50 UTR. The presence of a smaller fragment following HpaII
assays for each tissue was used. Ade, adenoma.
A contains two ORFs, ORF1 and ORF2. Actin, loading control.
A and shRNA-mediated RAD21 KD in LIM1215 cells.
nd the vector control. Identical exposure for all images. Note the stronger GFP
T116 cells. Note the reduced GFP signal in siRNA-transfected cells. In some
eft: western blots validating the expression of RAD21 and the GFP reporter.
in black and white. Rad21 or L1 (green) and DNA (red) colocalization (yellow) in
xpression is predominantly cytoplasmic and, in some cases, in the nucleus (red
ssion in human CRC. n = 142 cases. ***p < 0.001.
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SUPPLEMENTAL INFORMATION
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six figures, and eight tables and can be found with this article online at
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